Skip to main content
Hanshang Group Co.,Ltd. logo

Hanshang Group Co.,Ltd. — Investor Relations & Filings

Ticker · 600774 ISIN · CNE000000NC5 Shanghai Stock Exchange Wholesale and retail trade
Filings indexed 1,570 across all filing types
Latest filing 2021-04-20 Declaration of Voting R…
Country CN China
Listing Shanghai Stock Exchange 600774

About Hanshang Group Co.,Ltd.

https://www.whhsg.com/

Hanshang Group Co.,Ltd. is a diversified enterprise focused on commercial operations, exhibition services, and healthcare. The company manages a portfolio of large-scale department stores, shopping malls, and specialized retail outlets. Its exhibition segment provides comprehensive venue management and event organization services for international and domestic trade fairs. Hanshang Group has significantly expanded its presence in the healthcare sector through the development and distribution of pharmaceuticals, medical devices, and health-related products. By integrating traditional commercial assets with modern biomedical research and health management services, the group targets a broad consumer base and professional medical markets, emphasizing a strategic transition toward a comprehensive health-oriented business model.

Recent filings

Filing Released Lang Actions
汉商集团2020年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a "2020 Annual General Meeting Resolution Announcement" for 汉商集团股份有限公司. It details the date and location of the AGM, attendance, voting results on various proposals including the 2020 annual report, financial statements, board reports, profit distribution, and appointment of auditors. It also includes legal witness statements confirming the validity of the meeting and voting process. The content is focused on the resolutions passed at the AGM and the voting outcomes rather than the full annual report or financial statements themselves. The document length is 3233 characters, which is relatively short and consistent with an announcement of voting results rather than a full report. Therefore, this document fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2021-04-20 Chinese
汉商集团关于控股孙公司取得辐射安全许可证的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the acquisition of a radiation safety license by a subsidiary of the company. It contains no financial data, no discussion of financial results, no management commentary, and no regulatory certifications or filings related to financial performance. It is a regulatory announcement about a business license acquisition, which does not fit into categories like Annual Report, Interim Report, or Earnings Release. The document is brief (653 characters) and serves as a formal notification to investors about a non-financial operational update. Therefore, it best fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2021-04-15 Chinese
汉商集团第十届董事会第二十五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a board meeting resolution announcement from 汉商集团股份有限公司, detailing the approval of a proposal to apply for a merger loan from a bank. It references the meeting date, voting results, and compliance with company law and articles of association. The document is short (405 characters) and serves as an announcement of a board decision rather than a full report or detailed financial disclosure. It also references another announcement (编号 2021-020) for more details. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors.
2021-04-12 Chinese
汉商集团关于向银行申请并购借款的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by 汉商集团股份有限公司 regarding the application for a merger and acquisition loan to finance the purchase of 100% equity in 成都迪康药业股份有限公司. It details the board meetings approving the loan application, the loan amount, terms, collateral, and the impact on the company. The document is a formal announcement about financing related to an M&A transaction, not the M&A transaction filing itself or a full financial report. It does not contain financial statements or detailed financial analysis but focuses on the financing update for the acquisition. Therefore, it fits best under Capital/Financing Update (CAP). The document length is short (1143 characters), and it is not merely a report publication announcement or certification. Hence, the classification is CAP with high confidence.
2021-04-12 Chinese
汉商集团关于2020年度业绩说明会召开情况的公告
Investor Presentation Classification · 90% confidence The document is titled as an announcement regarding the holding of the 2020 annual performance explanation meeting (业绩说明会召开情况的公告). It details the company's interaction with investors during the meeting, including questions and answers about business strategy, financial performance, and future plans. The document does not contain full financial statements or comprehensive financial data but rather a summary of the meeting and responses to investor inquiries. The length is 3863 characters, which is relatively short and consistent with an announcement rather than a full report. There is no indication that this is a transcript of a conference call, nor is it a formal earnings release or annual report. The content fits best with an Investor Presentation (IP) or a Call Transcript (CT), but since it is a written Q&A session held on an online platform and described as an '业绩说明会' (performance explanation meeting), it aligns more closely with an Investor Presentation type document rather than a full transcript of a call. Therefore, the best classification is Investor Presentation (IP).
2021-04-09 Chinese
汉商集团关于非公开发行股票会后重大事项的承诺函
Regulatory Filings Classification · 95% confidence The document is a commitment letter from Hanshang Group Co., Ltd. regarding major post-meeting matters related to a non-public stock issuance. It references the approval by the China Securities Regulatory Commission and discusses the company's 2020 annual operating performance, financial data, and compliance with regulatory requirements. The document includes detailed financial figures and explanations but is primarily focused on confirming that no major adverse events have occurred after the issuance approval that would affect the non-public stock issuance. It also mentions audit reports have been issued but does not itself contain a full annual report or audit report. The document is a formal regulatory submission related to the non-public issuance process and compliance, rather than the actual annual report or audit report. It is a post-issuance commitment letter fulfilling regulatory disclosure requirements. Therefore, it fits best under Regulatory Filings (RNS) as a compliance and disclosure document that does not constitute a full financial report or audit report itself.
2021-04-08 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.